Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
Details for Australian Patent Application No. 2001252262 (hide)
International Classifications
Event Publications
2 February 2006 Application Accepted
Published as AU-B-2001252262
11 May 2006 Application for Amendment
The nature of the amendment is: Amend the name of the applicant/patentee from Bio Life Science Forschungs und Entwicklungsgesellschaft mbH to Biolife Science Forschungs-und Entwicklungsgesellschaft m.b.H. Address for service in Australia - Griffith Hack 509 St Kilda Road Melbourne VIC 3004
28 September 2006 Change of Name(s) of Applicant(s), Section 104
Bio Life Science Forschungs-und Entwicklungsgesellschaft m.b.H The name of the applicant has been changed to Biolife Science Forschungs-und Entwicklungsgesellschaft m.b.H
28 September 2006 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser